Investigational Site Number : 0320003

Salta 4400

0 studies enrolling now · 2 studies all time

What they study most

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule — Running, not enrolling
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early